- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 98,450 | 16.08.24 17:35:40 | +0,470 | +0,48% | 0,000 | 0,000 | 98,350 | 98,450 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 1.075,000 | 16.08.24 14:12:16 | +10,000 | +0,94% | 0,000 | 0,000 | 1.076,000 | 1.075,000 |
